The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma

Hammons, L., Szabo, A., Janardan, A., Bhatlapenumarthi, V., Annyapu, E., Dhakal, B., Al Hadidi, S., Radhakrishnan, S. V., Narra, R., Bhutani, D., Thanendrarajan, S., Janz, S., Zangari, M., Lentzsch, S., Van Rhee, F., Crescencio, J. C. R., D’Souza, A., Chakraborty, R., Mohan, M., & Schinke, C. (2023). The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma. Haematologica, 109(3), 906–914. https://doi.org/10.3324/haematol.2023.283590
Authors:
Lindsay Hammons
Vineel Bhatlapenumarthi
Binod Dhakal
Sabarinath Venniyil Radhakrishnan
Ravi Narra
Siegfried Janz
Anita D'Souza
Rajshekhar Chakraborty
Aniko Szabo
Abhishek Janardan
Evanka Annyapu
Samer Al Hadidi
Sharmilan Thanendrarajan
Maurizio Zangari
Frits van Rhee
Carolina Schinke
Divaya Bhutani
Suzanne Lentzsch
Juan Carlos Rico Crescencio
Affiliated Authors:
Rajshekhar Chakraborty
Divaya Bhutani
Suzanne Lentzsch
Publication Type:
Article
Unique ID:
10.3324/haematol.2023.283590
PMID:
Journal:
Publication Date:
Data Source:
Web of Science

Record Created: